- Home
- Products
- Customized ADCs
- PTK7
- Anti-PTK7-VC-auristatin ADC
Anti-PTK7-VC-auristatin ADC (CAT#: ADC-W-560)
This ADC product is comprised of an anti-PTK7 monoclonal antibody conjugated via a linker to auristatin. The auristatin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, auristatin binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- PTK7
- Alternative Names
- PTK7; protein tyrosine kinase 7 (inactive); CCK4; CCK-4; inactive tyrosine-protein kinase 7; colon carcinoma kinase 4; PTK7 protein tyrosine kinase 7; tyrosine-protein kinase-like 7; pseudo tyrosine kinase receptor 7;
- Target Entrez Gene ID
- 5754
- Target UniProt ID
- Q13308
- Overview
- This gene encodes a member of the receptor protein tyrosine kinase family of proteins that transduce extracellular signals across the cell membrane. The encoded protein lacks detectable catalytic tyrosine kinase activity, is involved in the Wnt signaling pathway and plays a role in multiple cellular processes including polarity and adhesion. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
- Overview
- Anti-PTK7 Antibody
- Species Reactivity
- Human
- Name
- VC (valine-citrulline)
- Description
- Peptide linkers, belonging to Enzymatically cleavable linkers, combine greater systemic stability with rapid enzymatic release of the drug in the target cell. The scission of peptidic bonds relies on lysosomal proteolytic enzymes, which have very low activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood.
- Name
- Auristatin
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-S. epidermidis LTA (Pagibaximab)-SMCC-DM1 ADC (CAT#: ADC-W-2258)
- Anti-KIRD2 (lirilumab)-SPDB-DM4 ADC (CAT#: ADC-W-2079)
- Anti-EGFR (Zalutumumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2587)
- Anti-CFD (Lampalizumab)-SPDB-DM4 ADC (CAT#: ADC-W-981)
- Anti-IL23A (Tildrakizumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1355)
- Anti-IFNAR (Anifrolumab)-SMCC-DM1 ADC (CAT#: ADC-W-2054)
- Anti-ITGA2 (Vatelizumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1457)
- Anti-CD22-SMCC-DM1 ADC-5 (CAT#: ADC-W-182)
- Anti-VEGFA (Vanucizumab)-SMCC-DM1 ADC (CAT#: ADC-W-2288)
- Anti-TNFRSF10B (Tigatuzumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1884)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-560. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-AA-048 | Protein G-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-564 | Anti-MUC16-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-536 | Anti-EDNRB (endothelin B)-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-514 | Anti-ERBB2 (Trastuzumab)-VC-DUBA ADC | VC (valine-citrulline) | seco-DUBA (DUocarmycin hydroxyBenzamide Azaindole) |
| ADC-W-494 | Anti-SLC39A6-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-419 | Anti-ERBB2 (Trastuzumab)-auristatin ADC | auristatin | |
| ADC-W-561 | Anti-LYPD3-auristatin ADC | Auristatin |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
